Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Milestone Pharmaceuticals Inc (MIST)

Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ GlobeNewswire - Thu May 14, 7:30AM CDT

MONTREAL and CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 1.2300 (-4.65%)
MarketBeat.com
Milestone Pharmaceuticals Q1 Earnings Call Highlights MarketBeat - Wed May 13, 1:09PM CDT

Milestone Pharmaceuticals (NASDAQ:MIST) said its first quarter of 2026 marked the beginning of commercial sales for CARDEMYST, its newly approved treatment for acute episodes of paroxysmal supraventricular...

MIST : 1.2300 (-4.65%)
Milestone Pharmaceuticals: Q1 Earnings Snapshot AP - Wed May 13, 6:18AM CDT

Milestone Pharmaceuticals: Q1 Earnings Snapshot

MIST : 1.2300 (-4.65%)
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire - Wed May 13, 6:11AM CDT

CARDAMYST™ (etripamil) nasal spray launch for PSVT is  gaining traction ; breadth of unique prescribers supports potential future adoption Express Scripts national formulary coverage secured as...

MIST : 1.2300 (-4.65%)
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026 GlobeNewswire - Wed May 6, 7:00AM CDT

MONTREAL and CHARLOTTE, May 06, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 1.2300 (-4.65%)
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT GlobeNewswire - Fri Apr 10, 7:00AM CDT

MONTREAL and CHARLOTTE, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 1.2300 (-4.65%)
Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference GlobeNewswire - Tue Apr 7, 7:30AM CDT

MONTREAL and CHARLOTTE, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development of commercialization of innovative...

MIST : 1.2300 (-4.65%)
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Thu Apr 2, 7:00AM CDT

MONTREAL and CHARLOTTE, N.C., April 02, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity...

MIST : 1.2300 (-4.65%)
Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies GlobeNewswire - Tue Mar 31, 7:00AM CDT

MONTREAL and CHARLOTTE, N.C., March 31, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 1.2300 (-4.65%)
Milestone Pharmaceuticals: Q4 Earnings Snapshot AP - Fri Mar 20, 6:37AM CDT

Milestone Pharmaceuticals: Q4 Earnings Snapshot

MIST : 1.2300 (-4.65%)

Barchart Exclusives

Why Coca-Cola and Walmart Top This List of Steady, Low-Volatility Dividend Aristocrats Barchart - Fri Jun 5, 6:00PM CDT
Dividend Aristocrats can offer income, stability, and consistency. Here are four lower-volatility names analysts still like. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.